Controlled trial of azathioprine in Crohn's disease.
D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001772:Blood Cell Count; D001792:Blood Platelets; D001799:Blood Sedimentation; D002986:Clinical Trials as Topic; D003424:Crohn Disease / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D008111:Liver Function Tests; D008297:Male; D010919:Placebos; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011346:Prochlorperazine / Q000627:therapeutic use; D012075:Remission, Spontaneous; D012709:Serum Albumin / Q000032:analysis; D013997:Time Factors
D010919:Placebos; D012709:Serum Albumin; D011239:Prednisolone; D001379:Azathioprine; D011346:Prochlorperazine